Pulished Date August, 2019
ID: 2268
Share on
Share on

Asia-Pacific Antacid Market By Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT Outsourcing, Immunoassay, Digital Pathology, Next Generation Sequencing(NGS), Proteomics, Antacids With Antiflatulents) By Applications (Novel Dietary Fibers) By Ingredients (Protease, Modified Starch, Food & Beverage Starch, Gelatin, Collagen, Carbohydrase, Food & Beverage Sugars & Its Substitutes), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: August, 2019
ID: 2268
Pages: 145

Asia Pacific Antacids are a group of medications that helps in neutralize the content of acid reflux in the stomach. It provides fast relief of heartburn, one of the main symptoms of gastroesophageal reflux digestion and other symptoms are nausea, bloating or belching. Antacids include magnesium carbonate, aluminium hydroxide, and magnesium trisilicate. Some people have reported allergic reactions to antacids. Antacids incorporate magnesium carbonate, aluminium hydroxide, and magnesium trisilicate. A few people have announced unfavourably susceptible responses to antacids.

Antacids Market value was worth USD 2.92 billion in 2018 and estimated to be growing at a CAGR of 4.0%, to reach USD 3.55 billion by 2023. 

Drivers and Restraints:

The growing trend toward self-medication is increasing the demand for over-the-counter digestive products for the treatment of gastrointestinal disorders. Antacids are used to neutralize acidity and should therefore cause a dramatic increase in demand. According to a study conducted by the American Gastroenterological Association and published in the International Functional Foundation in February 2017, about one-third of the US population. Suffering from GERD. Market restraints include some side effects such as constipation, laxative effect and allergic reactions. In addition, people suffering from certain medical conditions are prone to adverse effects that worsen their state of health because people with heart disease may have problems due to the high amount of sodium present in antacids.

Market Segmentation:

The market is segmented by drug class, by Formulation type, by Distribution channel and by application technique. By Drug class type the market is categorized into Proton Pump Inhibitors, H2 Antagonist, Acid neutralizers, and Pro-motility agents. Amongst all Proton pump inhibitors segment led the market in 2017 and the trend is anticipated to continue in forecast period. However acid neutralizers segment emerge as significant segment because of their extensive use in occasional heartburn and their availability range. By Formulation type the market is segmented into tablet, liquid and power. Tablet is the leading segment in 2017 and is anticipated to be the highest growing segment due to convenience in administration, low pricing and largely available. By distribution channel the market is segmented into Hospital Pharmacies and retail pharmacies and other. Other segments include online pharmacies and drug store which led the market segment. Rising adoption e- commerce and increase in number of online stores are boosting the growth of the market.

Geographical Segmentation:

By geography the market is segmented into India, China, Korea, Japan and others. The demand for antacid market in the Asia-Pacific region is anticipated to be majorly driven by countries like China and India.

Key Players:

The main players in the market are GlaxoSmithKline plc, Abbott Laboratories and Pfizer, Inc. Sun Pharma has launched an Ayurvedic digestive remedy called Pepmelt to compete with popular antacids such as ENO (Consumer Health), Digene (Abbott India) and Pudin Hara( Dabur). And Gelusil (Pfizer)

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Submarkets                

                                5.1.1 Introduction           

                                5.1.2 Chromatography  

                                5.1.3 E-Clinical Trial Solutions      

                                5.1.4 Wireless Health, Clinical Trial Management Systems(CTMS)              

                                5.1.5 Healthcare IT outsourcing 

                                5.1.6 Immunoassay        

                                5.1.7 Digital Pathology   

                                5.1.8 Next Generation sequencing(NGS)             

                                5.1.9 Proteomics             

                                5.1.10 Magnesium Compounds

                                5.1.11 , Aluminium Compounds

                                5.1.12 Calcium Compounds         

                                5.1.13 Antacids with Antiflatulents          

                                5.1.14  Y-o-Y Growth Analysis, By Submarkets    

                                5.1.15  Market Attractiveness Analysis, By Submarkets  

                                5.1.16  Market Share Analysis, By Submarkets   

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Novel Dietary Fibers           

                                5.2.3 Y-o-Y Growth Analysis, By Application         

                                5.2.4  Market Attractiveness Analysis, By Application      

                                5.2.5  Market Share Analysis, By Application       

                5.3 Ingredients                 

                                5.3.1 Introduction           

                                5.3.2 Protease  

                                5.3.3 Modified Starch    

                                5.3.4 Food & Beverage Starch    

                                5.3.5 Gellatin     

                                5.3.6 Collagen   

                                5.3.7 Carbohydrase        

                                5.3.8 Food & Beverage Sugars & its substitutes 

                                5.3.9 Y-o-Y Growth Analysis, By Ingredients        

                                5.3.10  Market Attractiveness Analysis, By Ingredients   

                                5.3.11  Market Share Analysis, By Ingredients    

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Submarkets

                                                6.1.3.3 By Application

                                                6.1.3.5 By Ingredients

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Submarkets

                                                6.1.4.3 By Application

                                                6.1.4.4 By Ingredients

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Submarkets

                                                6.1.5.3 By Application

                                                6.1.5.4 By Ingredients

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 First Aid Only                             

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GSK                

                8.3 WellSpring Pharm                    

                8.4 Private Lable                              

                8.5 Pfizer                            

                8.6 Procter & Gamble                    

                8.7 Glaxosmithkline                       

                8.8 Boehringer Ingellheim Pharm                             

                8.9 Novaritis Consurmer Health                

                8.10 Johnson & Johnson                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Antacid Market By Submarkets, From 2018-2023( USD Billion )
  2. Asia-Pacific Chromatography Market By Region, From 2018-2023( USD Billion )
  3. Asia-Pacific E-Clinical Trial Solutions Market By Region, From 2018-2023( USD Billion )
  4. Asia-Pacific Wireless Health Market By Region, From 2018-2023( USD Billion )
  5. Asia-Pacific Clinical Trial Management System (CTMS) Market By Region, From 2018-2023( USD Billion )
  6. Asia-Pacific Healthcare IT Outsourcing Market By Region, From 2018-2023( USD Billion )
  7. Asia-Pacific Immunoassay Market By Region, From 2018-2023( USD Billion )
  8. Asia-Pacific Digital Pathology Market By Region, From 2018-2023( USD Billion )
  9. Asia-Pacific Next Generation Sequencing(NGS) Market By Region, From 2018-2023( USD Billion )
  10. Asia-Pacific Proteomics Market By Region, From 2018-2023( USD Billion )
  11. Asia-Pacific Antacids with Antiflatulents Market By Region, From 2018-2023( USD Billion )
  12. Asia-Pacific Antacid Market By Application, From 2018-2023( USD Billion )
  13. Asia-Pacific Novel Dietary Fibers Market By Region, From 2018-2023( USD Billion )
  14. Asia-Pacific Antacid Market By Ingredients, From 2018-2023( USD Billion )
  15. Asia-Pacific Protease Market By Region, From 2018-2023( USD Billion )
  16. Asia-Pacific Modified  Starch Market By Region, From 2018-2023( USD Billion )
  17. Asia-Pacific Food & Beverage Starch Market By Region, From 2018-2023( USD Billion )
  18. Asia-Pacific Gelatin Market By Region, From 2018-2023( USD Billion )
  19. Asia-Pacific Collagen Market By Region, From 2018-2023( USD Billion )
  20. Asia-Pacific Carbohydrase Market By Region, From 2018-2023( USD Billion )
  21. Asia-Pacific Food & Beverage Sugars & its subtitutes Market By Region, From 2018-2023( USD Billion )
  22. Japan Antacid Market By Submarkets, From 2018-2023( USD Billion )
  23. Japan Antacid Market By Application, From 2018-2023( USD Billion )
  24. Japan Antacid Market By Ingredients, From 2018-2023( USD Billion )
  25. China Antacid Market By Submarkets, From 2018-2023( USD Billion )
  26. China Antacid Market By Application, From 2018-2023( USD Billion )
  27. China Antacid Market By Ingredients, From 2018-2023( USD Billion )
  28. India Antacid Market By Submarkets, From 2018-2023( USD Billion )
  29. India Antacid Market By Application, From 2018-2023( USD Billion )
  30. India Antacid Market By Ingredients, From 2018-2023( USD Billion )
  31. Australia Antacid Market By Submarkets, From 2018-2023( USD Billion )
  32. Australia Antacid Market By Application, From 2018-2023( USD Billion )
  33. Australia Antacid Market By Ingredients, From 2018-2023( USD Billion )
  34. South Korea Antacid Market By Submarkets, From 2018-2023( USD Billion )
  35. South Korea Antacid Market By Application, From 2018-2023( USD Billion )
  36. South Korea Antacid Market By Ingredients, From 2018-2023( USD Billion )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample